Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
L. Daniel Browne currently holds 152,193 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, L. Daniel Browne has been a net seller of RVNC stock. They have purchased $100.0K and sold $4.2M worth of shares.
L. Daniel Browne's most recent insider trade was on Jun 28, 2019, when they sold 1,000 shares at $11.02 per share.
L. Daniel Browne serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 46 insider transactions totaling $4.3M over their tenure at the company.
L. Daniel Browne holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
L. Daniel Browne has shown a selling trading pattern, with $100.0K in total purchases and $4.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by L. Daniel Browne was on May 19, 2014, when they purchased $3.1M worth of RVNC shares. This transaction involved 96,000 shares at $32.22 per share.
L. Daniel Browne currently owns 152,193 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of L. Daniel Browne's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. L. Daniel Browne has 46 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for L. Daniel Browne and 40,000+ other insiders.